Codon Innovation

John Overdeck and Laura Overdeck make investment decisions directly, consistent with the lean, principal-led structure of a single-family office. Codon does not publish a roster of investment professionals, suggesting a flat decision-making architecture rather than a committee or delegated partner model. This mirrors the Overdecks' approach at Two Sigma, where John Overdeck remains involved in model design and capital allocation.

Codon Innovation is a separate legal entity funded entirely by John Overdeck's personal capital, primarily derived from his stake in Two Sigma. Codon does not manage Two Sigma corporate capital and maintains no formal investment advisory relationship with the firm. The two entities share only the Overdeck family connection, with Codon's life sciences and deep tech mandate deliberately distinct from Two Sigma's quantitative finance focus.

Codon concentrates on pre-seed and seed rounds, with occasional Series A and B follow-ons into existing portfolio companies. The office has backed companies as early as concept-stage, including synthetic biology platform companies requiring long development arcs before revenue. This early-stage posture reflects a willingness to underwrite technical risk that later-stage funds typically avoid.

Codon primarily makes direct equity investments in operating companies. However, the office has made select commitments to venture capital funds, particularly those with European biotech exposure where direct sourcing from New York is less efficient. The core strategy remains direct deal-making.

Codon occasionally co-invests alongside other family offices and venture firms with overlapping life sciences theses. The office has joined rounds syndicated by Andreessen Horowitz Bio Fund and other early-stage biotech investors, though it does not publicly solicit co-investment partners. Its flexible capital base allows it to lead rounds when proprietary deal flow warrants.

Yes, the Overdeck Family Foundation, founded by John and Laura Overdeck, supports STEM education, research, and data-driven approaches to philanthropy. This foundation operates as a separate 501(c)(3) entity with its own staff and board. Codon Innovation's investment activities are walled off from the foundation's grant-making, with no programmatic overlap between the two structures.

Codon has never disclosed explicit sector exclusions, but its investment pattern shows no activity in consumer internet, enterprise SaaS without a computational biology angle, or traditional software-as-a-service businesses. The office appears to avoid sectors where it cannot apply the quantitative and scientific analytical lens that defines its core life sciences and deep tech mandate.